These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30444838)

  • 41. Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.
    Botchway A; Buhnerkempe MG; Prakash V; Al-Akchar M; Adekola B; Flack JM
    Am J Hypertens; 2020 May; 33(6):528-533. PubMed ID: 31930338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.
    Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR
    Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
    Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal SBP targets in routine clinical care.
    Gitsels LA; Kulinskaya E; Bakbergenuly I; Steel N
    J Hypertens; 2019 Apr; 37(4):837-843. PubMed ID: 30817466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
    Chang TI; Reboussin DM; Chertow GM; Cheung AK; Cushman WC; Kostis WJ; Parati G; Raj D; Riessen E; Shapiro B; Stergiou GS; Townsend RR; Tsioufis K; Whelton PK; Whittle J; Wright JT; Papademetriou V;
    Hypertension; 2017 Oct; 70(4):751-758. PubMed ID: 28760939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial.
    Oxlund CS; Pareek M; Rasmussen BSB; Vaduganathan M; Biering-Sørensen T; Byrne C; Almarzooq Z; Olsen MH; Bhatt DL
    Am J Med; 2019 Jul; 132(7):840-846. PubMed ID: 30721655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.
    Verdecchia P; Angeli F; Gentile G; Reboldi G
    Hypertension; 2016 Sep; 68(3):642-53. PubMed ID: 27456518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
    Leitão L; Soares-Dos-Reis R; Neves JS; Baptista RB; Bigotte Vieira M; Mc Causland FR
    Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
    Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    Zhang W; Zhang S; Deng Y; Wu S; Ren J; Sun G; Yang J; Jiang Y; Xu X; Wang TD; Chen Y; Li Y; Yao L; Li D; Wang L; Shen X; Yin X; Liu W; Zhou X; Zhu B; Guo Z; Liu H; Chen X; Feng Y; Tian G; Gao X; Kario K; Cai J;
    N Engl J Med; 2021 Sep; 385(14):1268-1279. PubMed ID: 34491661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients.
    Men X; Sun W; Fan F; Zhao M; Huang X; Wang Y; Liu L; Liu R; Sun W; Peng Q; Qin X; Tang G; Li J; Zhang Y; Cai Y; Hou FF; Wang B; Xu X; Cheng X; Sun N; Huang Y; Huo Y
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.